Sarepta Therapeutics (STU:AB3A) Other Long Term Assets : €289 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sarepta Therapeutics Other Long Term Assets?

Sarepta Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was €289 Mil.

Sarepta Therapeutics's quarterly other long-term assets declined from Sep. 2023 (€268 Mil) to Dec. 2023 (€268 Mil) but then increased from Dec. 2023 (€268 Mil) to Mar. 2024 (€289 Mil).

Sarepta Therapeutics's annual other long-term assets increased from Dec. 2021 (€228 Mil) to Dec. 2022 (€271 Mil) but then declined from Dec. 2022 (€271 Mil) to Dec. 2023 (€268 Mil).

Sarepta Therapeutics Other Long Term Assets Historical Data

The historical data trend for Sarepta Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics Other Long Term Assets Chart

Sarepta Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

127.73

135.55

228.38

270.56

267.76

Sarepta Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															269.30	259.04	268.02	267.76	288.55

Sarepta Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Sarepta Therapeutics (STU:AB3A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (STU:AB3A) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

SRPT:USA S1RP34:Brazil

Address

215 First Street, Suite 415, Cambridge, MA, USA, 02142

Website

https://www.sarepta.com

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Sarepta Therapeutics (STU:AB3A) Headlines

No Headlines